PTC Therapeutics, Inc.SEC Filings
|
|
All SEC filings by PTC Therapeutics, Inc. (PTCT) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Jul 30, 2026 | |
| 10-Q | Quarterly report | View Diff | May 7, 2026 | |
| ARS | Annual report to shareholders | Apr 20, 2026 | ||
| 10-K | Annual report | View Diff | Feb 19, 2026 | |
| 10-Q | Quarterly report | View Diff | Nov 4, 2025 | |
| 10-Q | Quarterly report | View Diff | Aug 7, 2025 | |
| 10-Q | Quarterly report | View Diff | May 6, 2025 | |
| ARS | Annual report to shareholders | Apr 30, 2025 | ||
| 10-K | Annual report | View Diff | Feb 27, 2025 | |
| 10-Q | Quarterly report | View Diff | Nov 7, 2024 |
Events
| 8-K | Current report | Aug 28, 2026 | ||
| 8-K | Ptc to Expand Rare Disease Portfolio with Acquisition of Bla-Stage St-920 Fabry Disease Program | Aug 13, 2026 | ||
| 8-K | Ptc Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results | Jul 30, 2026 | ||
| 8-K | Current report | Jun 18, 2026 | ||
| 8-K | Current report | Jun 16, 2026 | ||
| 8-K | Current report | Jun 9, 2026 | ||
| 8-K | Current report | Jun 5, 2026 | ||
| 8-K | Results of Operations and Financial Condition | May 7, 2026 | ||
| 8-K | Ptc Therapeutics Reports Positive Topline Results From Month 24 Interim Analysis of Pivot-Hd Extension Study of Votoplam | Apr 28, 2026 | ||
| 8-K | Ptc Therapeutics Appoints Biotech Banking Pioneer | Mar 25, 2026 |
Registrations and Prospectuses
| POSASR | Automatic shelf registration (post-effective amendment) | Nov 7, 2023 | ||
| D | $35.90 Mm in Equity / Common Stock, Sold $35.90 Mm, 40 Investors | May 8, 2023 | ||
| S-3ASR | Automatic shelf registration | May 5, 2023 | ||
| POSASR | Automatic shelf registration (post-effective amendment) | Apr 28, 2023 | ||
| S-8 | Registration of securities for employees | Dec 16, 2022 | ||
| S-3ASR | Automatic shelf registration | Dec 16, 2022 | ||
| S-8 | Registration of securities for employees | Jun 23, 2022 | ||
| S-8 POS | Registration of securities for employees (post-effective amendment) | Apr 13, 2022 | ||
| S-8 | Registration of securities for employees | Jan 5, 2022 | ||
| POSASR | Automatic shelf registration (post-effective amendment) | Jan 7, 2021 |
Proxies
| DEFA14A | Additional proxy soliciting materials | Apr 20, 2026 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 20, 2026 | |
| DEFA14A | Additional proxy soliciting materials | Apr 30, 2025 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 30, 2025 | |
| DEFA14A | Additional proxy soliciting materials | Apr 26, 2024 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 26, 2024 | |
| DEFA14A | Additional proxy soliciting materials | Apr 26, 2023 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 26, 2023 | |
| DEFA14A | Additional proxy soliciting materials | Apr 28, 2022 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 28, 2022 |
Other
| UPLOAD | Letter from SEC | Oct 27, 2021 | ||
| CT ORDER | Confidential treatment order | Oct 19, 2021 | ||
| CORRESP | Correspondence with SEC | Oct 19, 2021 | ||
| UPLOAD | Letter from SEC | Oct 6, 2021 | ||
| CORRESP | Correspondence with SEC | Sep 23, 2021 | ||
| UPLOAD | Letter from SEC | Aug 26, 2021 | ||
| CT ORDER | Confidential treatment order | Sep 17, 2020 | ||
| CT ORDER | Confidential treatment order | Jul 15, 2020 | ||
| SEC STAFF | SEC staff action: Order | Feb 18, 2020 | ||
| SEC STAFF | SEC staff action: Order | Feb 7, 2020 |
Ownership
| 4 | Schmertzler Michael | Aug 28, 2026 | ||
| 144/A | Notice of proposed sale of securities | Aug 25, 2026 | ||
| 4 | Schmertzler Michael | Aug 21, 2026 | ||
| 4 | Boulding Mark Elliott | Aug 19, 2026 | ||
| 144 | Notice of proposed sale of securities | Aug 19, 2026 | ||
| 144 | Notice of proposed sale of securities | Aug 17, 2026 | ||
| 4 | Klein Matthew B. | Aug 6, 2026 | ||
| 144 | Notice of proposed sale of securities | Aug 4, 2026 | ||
| 4 | Sollie-Zetlmayer Hege Elisabeth | Jul 30, 2026 | ||
| 3 | Sollie-Zetlmayer Hege Elisabeth | Jul 30, 2026 |